Showing results (41-50 of 206) with videos related to
Sort By:
Pageof 21
Journal of Neuroimmunology|May 18, 2000
Expression of human IAP-like protein in skeletal muscle: a possible explanation for the rare incidence of muscle fiber apoptosis in T-cell mediated inflammatory myopathiesM Li, M C DalakasNeurology|October 1, 1996
The spectrum of familial inclusion body myopathies in 13 families and a description of a quadriceps-sparing phenotype in non-Iranian JewsK Sivakumar, M C DalakasCurrent Opinion in Neurology|June 1, 1996
The immunopathologic and inflammatory differences between dermatomyositis, polymyositis and sporadic inclusion body myositisM C Dalakas, K SivakumarThe Journal of Clinical Investigation|November 1, 1994
High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragmentsM Basta, M C DalakasActa Neuropathologica|January 1, 1986
Characterization of amyloid deposits in biopsies of 15 with "sporadic" (non-familial or plasma cell dyscrasia amyloid polyneuropathyM C Dalakas, G CunninghamAnnals of Neurology|April 20, 2001
Abnormal desmin protein in myofibrillar myopathies caused by desmin gene mutationsM Li, M C DalakasBrain : a Journal of Neurology|July 25, 2000
Expression of the co-stimulatory molecule BB-1, the ligands CTLA-4 and CD28 and their mRNAs in chronic inflammatory demyelinating polyneuropathyK Murata, M C DalakasNeurology|May 1, 1993
Treatment of inclusion-body myositis with high-dose intravenous immunoglobulinS A Soueidan, M C DalakasThe New England Journal of Medicine|April 25, 1991
Dysphagia in patients with the post-polio syndromeB C Sonies, M C DalakasClinical and Experimental Immunology|December 30, 2014
7th International Immunoglobulin Conference: Interlaken Leadership AwardsM C Dalakas, W N LöscherPageof 21